Betaine prevents homocysteine-induced memory impairment via matrix metalloproteinase-9 in the frontal cortex

Kazuo Kunisawa, N. Nakashima, M. Nagao, T. Nomura, S. Kinoshita, M. Hiramatsu

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Betaine plays important roles that include acting as a methyl donor and converting homocysteine (Hcy) to methionine. Elevated plasma Hcy levels are known as hyperhomocysteinemia (HHcy) and contribute to impairments of learning and memory. Although it is commonly known that betaine plays an important role in Hcy metabolism, the effects of betaine on Hcy-induced memory impairment have not been investigated. Previously, we demonstrated the beneficial effects of betaine on acute stress and lipopolysaccharide-induced memory impairment. In the present study, we investigated whether betaine ameliorates Hcy-induced memory impairment and the underlying mechanisms of this putative effect. Mice were treated with Hcy (0.162. mg/kg, s.c.) twice a day for nine days, and betaine (25 mg/kg, s.c.) was administered 30. min before the Hcy injections. The memory functions were evaluated using a spontaneous alternation performance test (Y-maze) at seven days and a step-down type passive avoidance test (SD) at nine and ten days after Hcy injection. We found that betaine suppressed the memory impairment induced by repeated Hcy injections. However, the blood concentrations of Hcy were significantly increased in the Hcy-treated mice immediately after the passive avoidance test, and betaine did not prevent this increase. Furthermore, Hcy induces redox stress in part by activating matrix metalloproteinase-9 (MMP-9), which leads to BBB dysfunction. Therefore, we tested whether betaine affected MMP-9 activity. Interestingly, treatment with betaine significantly inhibited Hcy-induced MMP-9 activity in the frontal cortex but not in the hippocampus after acute Hcy injection. These results suggest that the changes in MMP-9 activity after betaine treatment might have been partially responsible for the amelioration of the memory deficits and that MMP-9 might be a candidate therapeutic target for HHcy.

Original languageEnglish
Pages (from-to)36-43
Number of pages8
JournalBehavioural Brain Research
Volume292
DOIs
Publication statusPublished - 01-10-2015

Fingerprint

Betaine
Matrix Metalloproteinase 9
Frontal Lobe
Homocysteine
Hyperhomocysteinemia
Injections
Memory Disorders
Methionine
Oxidation-Reduction

All Science Journal Classification (ASJC) codes

  • Behavioral Neuroscience

Cite this

Kunisawa, Kazuo ; Nakashima, N. ; Nagao, M. ; Nomura, T. ; Kinoshita, S. ; Hiramatsu, M. / Betaine prevents homocysteine-induced memory impairment via matrix metalloproteinase-9 in the frontal cortex. In: Behavioural Brain Research. 2015 ; Vol. 292. pp. 36-43.
@article{9a194de70386435c9045d57d89eb61b5,
title = "Betaine prevents homocysteine-induced memory impairment via matrix metalloproteinase-9 in the frontal cortex",
abstract = "Betaine plays important roles that include acting as a methyl donor and converting homocysteine (Hcy) to methionine. Elevated plasma Hcy levels are known as hyperhomocysteinemia (HHcy) and contribute to impairments of learning and memory. Although it is commonly known that betaine plays an important role in Hcy metabolism, the effects of betaine on Hcy-induced memory impairment have not been investigated. Previously, we demonstrated the beneficial effects of betaine on acute stress and lipopolysaccharide-induced memory impairment. In the present study, we investigated whether betaine ameliorates Hcy-induced memory impairment and the underlying mechanisms of this putative effect. Mice were treated with Hcy (0.162. mg/kg, s.c.) twice a day for nine days, and betaine (25 mg/kg, s.c.) was administered 30. min before the Hcy injections. The memory functions were evaluated using a spontaneous alternation performance test (Y-maze) at seven days and a step-down type passive avoidance test (SD) at nine and ten days after Hcy injection. We found that betaine suppressed the memory impairment induced by repeated Hcy injections. However, the blood concentrations of Hcy were significantly increased in the Hcy-treated mice immediately after the passive avoidance test, and betaine did not prevent this increase. Furthermore, Hcy induces redox stress in part by activating matrix metalloproteinase-9 (MMP-9), which leads to BBB dysfunction. Therefore, we tested whether betaine affected MMP-9 activity. Interestingly, treatment with betaine significantly inhibited Hcy-induced MMP-9 activity in the frontal cortex but not in the hippocampus after acute Hcy injection. These results suggest that the changes in MMP-9 activity after betaine treatment might have been partially responsible for the amelioration of the memory deficits and that MMP-9 might be a candidate therapeutic target for HHcy.",
author = "Kazuo Kunisawa and N. Nakashima and M. Nagao and T. Nomura and S. Kinoshita and M. Hiramatsu",
year = "2015",
month = "10",
day = "1",
doi = "10.1016/j.bbr.2015.06.004",
language = "English",
volume = "292",
pages = "36--43",
journal = "Behavioural Brain Research",
issn = "0166-4328",
publisher = "Elsevier",

}

Betaine prevents homocysteine-induced memory impairment via matrix metalloproteinase-9 in the frontal cortex. / Kunisawa, Kazuo; Nakashima, N.; Nagao, M.; Nomura, T.; Kinoshita, S.; Hiramatsu, M.

In: Behavioural Brain Research, Vol. 292, 01.10.2015, p. 36-43.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Betaine prevents homocysteine-induced memory impairment via matrix metalloproteinase-9 in the frontal cortex

AU - Kunisawa, Kazuo

AU - Nakashima, N.

AU - Nagao, M.

AU - Nomura, T.

AU - Kinoshita, S.

AU - Hiramatsu, M.

PY - 2015/10/1

Y1 - 2015/10/1

N2 - Betaine plays important roles that include acting as a methyl donor and converting homocysteine (Hcy) to methionine. Elevated plasma Hcy levels are known as hyperhomocysteinemia (HHcy) and contribute to impairments of learning and memory. Although it is commonly known that betaine plays an important role in Hcy metabolism, the effects of betaine on Hcy-induced memory impairment have not been investigated. Previously, we demonstrated the beneficial effects of betaine on acute stress and lipopolysaccharide-induced memory impairment. In the present study, we investigated whether betaine ameliorates Hcy-induced memory impairment and the underlying mechanisms of this putative effect. Mice were treated with Hcy (0.162. mg/kg, s.c.) twice a day for nine days, and betaine (25 mg/kg, s.c.) was administered 30. min before the Hcy injections. The memory functions were evaluated using a spontaneous alternation performance test (Y-maze) at seven days and a step-down type passive avoidance test (SD) at nine and ten days after Hcy injection. We found that betaine suppressed the memory impairment induced by repeated Hcy injections. However, the blood concentrations of Hcy were significantly increased in the Hcy-treated mice immediately after the passive avoidance test, and betaine did not prevent this increase. Furthermore, Hcy induces redox stress in part by activating matrix metalloproteinase-9 (MMP-9), which leads to BBB dysfunction. Therefore, we tested whether betaine affected MMP-9 activity. Interestingly, treatment with betaine significantly inhibited Hcy-induced MMP-9 activity in the frontal cortex but not in the hippocampus after acute Hcy injection. These results suggest that the changes in MMP-9 activity after betaine treatment might have been partially responsible for the amelioration of the memory deficits and that MMP-9 might be a candidate therapeutic target for HHcy.

AB - Betaine plays important roles that include acting as a methyl donor and converting homocysteine (Hcy) to methionine. Elevated plasma Hcy levels are known as hyperhomocysteinemia (HHcy) and contribute to impairments of learning and memory. Although it is commonly known that betaine plays an important role in Hcy metabolism, the effects of betaine on Hcy-induced memory impairment have not been investigated. Previously, we demonstrated the beneficial effects of betaine on acute stress and lipopolysaccharide-induced memory impairment. In the present study, we investigated whether betaine ameliorates Hcy-induced memory impairment and the underlying mechanisms of this putative effect. Mice were treated with Hcy (0.162. mg/kg, s.c.) twice a day for nine days, and betaine (25 mg/kg, s.c.) was administered 30. min before the Hcy injections. The memory functions were evaluated using a spontaneous alternation performance test (Y-maze) at seven days and a step-down type passive avoidance test (SD) at nine and ten days after Hcy injection. We found that betaine suppressed the memory impairment induced by repeated Hcy injections. However, the blood concentrations of Hcy were significantly increased in the Hcy-treated mice immediately after the passive avoidance test, and betaine did not prevent this increase. Furthermore, Hcy induces redox stress in part by activating matrix metalloproteinase-9 (MMP-9), which leads to BBB dysfunction. Therefore, we tested whether betaine affected MMP-9 activity. Interestingly, treatment with betaine significantly inhibited Hcy-induced MMP-9 activity in the frontal cortex but not in the hippocampus after acute Hcy injection. These results suggest that the changes in MMP-9 activity after betaine treatment might have been partially responsible for the amelioration of the memory deficits and that MMP-9 might be a candidate therapeutic target for HHcy.

UR - http://www.scopus.com/inward/record.url?scp=84934906333&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84934906333&partnerID=8YFLogxK

U2 - 10.1016/j.bbr.2015.06.004

DO - 10.1016/j.bbr.2015.06.004

M3 - Article

C2 - 26057356

AN - SCOPUS:84934906333

VL - 292

SP - 36

EP - 43

JO - Behavioural Brain Research

JF - Behavioural Brain Research

SN - 0166-4328

ER -